Ramón
García Sanz
Profesor Titular de Universidad
Instituto de Investigación Biomédica de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Biomédica de Salamanca (41)
2024
-
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
Infection
-
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry
Hematological Oncology, Vol. 42, Núm. 1
2023
-
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings
International Journal of Infectious Diseases, Vol. 137, pp. 98-110
-
Characterization of the first HLA-DQA1 allele with Aspartic Acid in the transmembrane domain, HLA-DQA1*05:71
HLA, Vol. 102, Núm. 3, pp. 381-383
-
Detection and characterization of the novel HLA-DPA1*02:66:02N allele, with a premature stop codon in exon 2
Human Immunology, Vol. 84, Núm. 4, pp. 296-300
-
Identification of the novel HLA-DQA1*01:04:07 allele with a synonymous substitution and an intronic insertion
HLA, Vol. 101, Núm. 5, pp. 559-561
-
Identification of two novel HLA-DQB1*03:01:01 intronic variants: HLA-DQB1*03:01:01:47 and -DQB1*03:01:01:48
HLA, Vol. 101, Núm. 5, pp. 562-564
-
The novel HLA-DQB1*03:02:01:14 allele was possibly generated by a recombination event
HLA, Vol. 102, Núm. 2, pp. 258-260
-
Transitions in intronic regions result in two novel HLA-DQB1 alleles: –DQB1*05:02:01:13 and -DQB1*05:02:01:14
HLA, Vol. 102, Núm. 2, pp. 260-262
2022
-
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 40, Núm. 11, pp. 1196-1205
-
Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report
American Journal of Hematology
-
Ponatinib, chemotherapy, and transplant in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia
Blood Advances, Vol. 6, Núm. 18, pp. 5395-5402
-
RNA sequencing identifies novel regulated IRE1-dependent decay targets that affect multiple myeloma survival and proliferation
Experimental Hematology and Oncology, Vol. 11, Núm. 1
-
The novel HLA-DQB1*03:493 allele, the first with glutamic acid at position—10 in the leader peptide
HLA, Vol. 100, Núm. 6, pp. 665-667
2021
-
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
Journal of Hematology and Oncology, Vol. 14, Núm. 1
-
Stratification and management of cardiovascular risk in cancer patients. A consensus document of the SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC, and AECC
Revista Espanola de Cardiologia, Vol. 74, Núm. 5, pp. 438-448
-
Stroma-Mediated Resistance to S63845 and Venetoclax through MCL-1 and BCL-2 Expression Changes Induced by miR-193b-3p and miR-21-5p Dysregulation in Multiple Myeloma
Cells, Vol. 10, Núm. 3
2019
-
Atrial Fibrillation in Active Cancer Patients: Expert Position Paper and Recommendations
Revista Espanola de Cardiologia, Vol. 72, Núm. 9, pp. 749-759
-
Current Status of Cardio-Oncology in Spain: A National Multidisciplinary Survey
Revista Espanola de Cardiologia, Vol. 72, Núm. 1, pp. 84-86
-
Transcriptome analysis reveals significant differences between primary plasma cell leukemia and multiple myeloma even when sharing a similar genetic background
Blood Cancer Journal, Vol. 9, Núm. 12